These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8476902)

  • 1. Activation of the alternative pathway of complement in hyperacute xenograft rejection of rabbit hearts by human blood.
    Forty J; White DJ; Wallwork J
    J Heart Lung Transplant; 1993; 12(2):283-6; discussion 286-7. PubMed ID: 8476902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperacute rejection of rabbit hearts by human blood is mediated by the alternative pathway of complement.
    Forty J; Hasan R; Cary N; White DJ; Wallwork J
    Transplant Proc; 1992 Apr; 24(2):488-9. PubMed ID: 1566398
    [No Abstract]   [Full Text] [Related]  

  • 4. A technique for perfusion of an isolated working heart to investigate hyperacute discordant xenograft rejection.
    Forty J; White DG; Wallwork J
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):308-16. PubMed ID: 8341072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antibody and complement on perfused hearts: a model for the study of xenograft rejection phenomenon.
    Pinto ME; Nelson RA
    Z Immunitatsforsch Exp Klin Immunol; 1975 May; 149(1):78-93. PubMed ID: 127459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the alternative pathway of complement is an important component of hyperacute rejection of rabbit hearts by human blood.
    Forty J; Hasan R; Cary N; White DJ; Wallwork J
    Transpl Int; 1992; 5 Suppl 1():S311-2. PubMed ID: 14621809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.
    Pfeiffer S; Zorn GL; Zhang JP; Giorgio TD; Robson SC; Azimzadeh AM; Pierson RN
    Transplantation; 2003 Apr; 75(7):953-9. PubMed ID: 12698079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection.
    Kroshus TJ; Dalmasso AP; Leventhal JR; John R; Matas AJ; Bolman RM
    J Surg Res; 1995 Jul; 59(1):43-50. PubMed ID: 7630135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
    Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
    Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse-to-rabbit xenotransplantation: a new small animal model of hyperacute rejection mediated by the classical complement pathway.
    Kerr SR; Dalmasso AP; Apasova EV; Chen SS; Kirschfink M; Matas AJ
    Transplantation; 1999 Feb; 67(3):360-5. PubMed ID: 10030279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation cascade activation triggers early failure of pig hearts expressing human complement regulatory genes.
    Wu G; Pfeiffer S; Schröder C; Zhang T; Nguyen BN; Kelishadi S; Atkinson JB; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
    Xenotransplantation; 2007 Jan; 14(1):34-47. PubMed ID: 17214703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
    Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
    Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia virus complement control protein inhibits hyperacute xenorejection in a guinea pig-to-rat heterotopic cervical cardiac xenograft model by blocking both xenoantibody binding and complement pathway activation.
    Anderson JB; Smith SA; van Wijk R; Chien S; Kotwal GJ
    Transpl Immunol; 2003; 11(2):129-35. PubMed ID: 12799195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement mediates attenuation of endothelium-dependent relaxations in canine coronary arteries after porcine serum exposure: a mechanism for vascular thrombosis in xenograft hyperacute rejection.
    Cable DG; Hisamochi K; Schaff HV
    Circulation; 1997 Nov; 96(9 Suppl):II-58-63; discussion II-63-4. PubMed ID: 9386076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant role of complement in the hyperacute xenograft rejection reaction.
    Schilling A; Land W; Pratschke E; Pielsticker K; Brendel W
    Surg Gynecol Obstet; 1976 Jan; 142(1):29-32. PubMed ID: 1105839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
    Malassagne B; Calmus Y; Houssin D; Weill B
    Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts.
    Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH
    J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperacute rejection of renal discordant xenograft (pig-to-rabbit): model assessment and rejection mechanisms.
    Marino IR; Ferla G; Celli S; Stieber A; Muttillo I; Maggiano N; Mazzaferro V; Perrelli L; Musiani P
    Transplant Proc; 1990 Jun; 22(3):1071-6. PubMed ID: 2190372
    [No Abstract]   [Full Text] [Related]  

  • 19. Intervention strategies and agents mediating the prevention of xenorejection.
    Ghebremariam YT; Smith SA; Anderson JB; Kahn D; Kotwal GJ
    Ann N Y Acad Sci; 2005 Nov; 1056():123-43. PubMed ID: 16387682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs.
    Rollins SA; Matis LA; Springhorn JP; Setter E; Wolff DW
    Transplantation; 1995 Dec; 60(11):1284-92. PubMed ID: 8525523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.